MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Novartis

  • Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals’ Patent
    Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals’ Patent
    The Supreme Court has granted a temporary emergency stay of a lower court order that Novartis Pharmaceuticals says would allow the development of as many as 20 generic versions of ...
    September 29, 2022BY Matthew Vadum
  • Novartis Reports Zolgensma Caused 2 Deaths From Liver Failure
    Novartis Reports Zolgensma Caused 2 Deaths From Liver Failure
    Novartis AG on Thursday reported two patient fatalities due to acute liver failure following treatment with Zolgensma gene ...
    August 16, 2022BY Reuters
  • Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma
    Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma
    A U.S. appeals court overruled its prior decision, deciding that the patent for Novartis AG’s blockbuster drug Gilenya ...
    June 30, 2022BY Marina Zhang
  • Novartis to Cut Up to 8,000 Jobs Globally
    Novartis to Cut Up to 8,000 Jobs Globally
    ZURICH—Novartis said on Tuesday a previously announced restructuring program could lead to 8,000 jobs being cut, or about ...
    June 29, 2022BY Reuters
  • Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has ...
    January 10, 2022BY Tom Ozimek
  • Novartis Says US Court Upholds Gilenya Patent
    Novartis Says US Court Upholds Gilenya Patent
    ZURICH—Novartis AG said on Tuesday a U.S. court of appeals upheld the validity of a dosage regimen patent ...
    January 5, 2022BY Reuters
  • Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    ZURICH—Novartis has signed an option, collaboration, and license agreement with BeiGene Ltd for anti-cancer therapy ociperlimab (BGB-A1217) to ...
    December 21, 2021BY Reuters
  • Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third ...
    November 27, 2021BY Reuters
  • Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Two drugmakers plan on testing a drug that blocks enzymes in COVID-19 patients on ventilators in the United States. ...
    May 6, 2020BY Zachary Stieber
  • Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...
    April 20, 2020BY Zachary Stieber
  • Novartis Korea Executives Charged With Bribing Doctors
    Novartis Korea Executives Charged With Bribing Doctors
    Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former ...
    August 13, 2016BY The Associated Press
  • New Drug Could Reduce Cardiovascular Deaths (Video)
    New Drug Could Reduce Cardiovascular Deaths (Video)
    Researchers have created a new drug believed to reduce cardiovascular deaths.  ​This new drug, LCZ696, was created by ...
    August 30, 2014BY Epoch Video
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    2hr By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    3hr By Jacki Thrapp
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    4hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    4hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    6hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    7hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    7hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    11hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    12hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
    19hr By Melanie Sun
    Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top